Christina Linder Stragliotto

Publications
CV
Public outreach and news

Articles

Article: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026;:1-12
Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease
Linder-Stragliotto C; Tsagkozis P; Potdar S; Brodin CA; Brodin BA
Article: ACTA ONCOLOGICA. 2026;65:32-35
Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report
Lapins J; Radros N; Schultz K; Vassilaki I; Stragliotto CL; Helgadotti H
Article: CANCER REPORTS. 2025;8(11):e70406
Oncological Outcome for 83 Consecutive Patients With Malignant Peripheral Nerve Sheath Tumors Treated at a Tertiary Referral Centre
Yeomans HVM; Lloyd KC; De Flon FH; Mansoori S; Tsagkozis P; Linder Stragliotto CM
Article: RADIATION ONCOLOGY. 2025;20(1):139
Improved local control using higher dose SBRT in metastatic sarcoma patients
Hedman M; Rossi E; Dalqvist E; Karlsson K; Linder-Stragliotto C
Article: CLINICAL CANCER RESEARCH. 2024;30(12):2647-2658
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma
Ofverholm I; Wallander K; Haglund C; Chellappa V; Wejde J; Gellerbring A; Wirta V; Renevey A; Caceres E; Tsagkozis P; Mayrhofer M; Papakonstantinou A; Linder-Stragliotto C; Branstrom R; Larsson O; Lindberg J; Lin Y; de Flon FH
Article: INTERNATIONAL JOURNAL OF CANCER. 2022;151(6):906-913
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center
Renberg S; Zhang Y; Karlsson F; Branstrom R; Ahlen J; Jalmsell L; Linder-Stragliotto C; Haglund de Flon F; Papakonstantinou A
Article: BIOMOLECULES. 2022;12(2):292
Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
Zhang Y; Chen Y; Papakonstantinou A; Tsagkozis P; Linder-Stragliotto C; Haglund F
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2020;69(11):2393-2401
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
Frobom R; Berglund E; Berglund D; Nilsson I-L; Ahlen J; von Sivers K; Linder-Stragliotto C; Suenaert P; Karlsson-Parra A; Branstrom R

All other publications

Review: JCO PRECISION ONCOLOGY. 2025;9:e2500377
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.
Juan Ribelles A; Felix A; Benavent N; Escrivá-Fernández J; Brahmi M; Gaspar N; Gatz SA; Grünewald TGP; Linder-Stragliotto C; Palmerini E; Pantziarka P; Strauss S; Surdez D; Berlanga P; McCabe MG
Doctoral thesis: 1998
Positive and negative angiogenic factors in patients with malignant disease
Linder C

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2024-2027

Degrees and Education

Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 1998
University Medical Degree, Karolinska Institutet, 1994

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI